Reporter Staff

Reporter Staff

| This email address is being protected from spambots. You need JavaScript enabled to view it.

UAB employees who want to ensure their financial security in their golden years can take advantage of services provided by the UAB Benefits Office and UAB’s retirement providers, including retirement counseling and investment support for mandatory and voluntary retirement plans. If you are contacted by other vendors claiming to be authorized, do not give out your personal information. 

Beginning Aug. 30, all Equipment Disposition Forms (EDF) will be submitted online. The new form and instruction guide will be accessible through the EDF app on the myUAB portal and can also be found on the Financial Affairs website.

About the Clinical Trial:

The purpose of this NIH funded trial is to examine the effects of three different diabetes treatments to determine if they improve night-time blood sugars.

This Trial Involves:

  • A screening visit that includes a blood draw, urine test and physical exam
  • Treatment with Metformin, Insulin Glargine (long-acting insulin) or the experimental drug Dorzagliatin which is FDA-approved for research, for up to 8 weeks
  • 2-4 inpatient visits/ including two overnight stays at the Clinical Research Unit at 15th floor of Jefferson Tower.

All visits to be completed within a three-month period. Study-related tests and procedures are provided free of charge. Participants will be compensated up to $2,500 for study completion. All Participants must be Diagnosed with type 2 DM and Not on any type of insulin therapy.

Please contact Kathryn Hollifield-Laumer at khollifield@uabmc.edu or co-investigators Chanel Mason at 205-934-1921 or cnmason@uabmc.edu, or Alaaeldin Hodhod at ahodhod@uabmc.edu.

UAB’s student-centered email newsletter transitions to a new name and template on Aug. 21. Blazer Weekly will continue to be distributed on Wednesdays to all enrolled UAB students. Faculty and staff who would like to subscribe may do so via the UAB Subscription Center.

UAB Chief Financial Officer Stephanie Mullins will serve as UAB’s inaugural Vice President for Strategic Initiatives, effective Oct. 1.

We are currently recruiting participants aged 18-30 with normal or corrected to normal vision and participants aged 18-89 with Macular Degeneration/Stargardt's Disease for a clinical research study that aims to understand how individuals learn to use their peripheral vision following the loss of central vision. This study is being conducted in the Civitan International Research Center and involves a total of 27 in-person visits over the course of 1.5 to 3 months. There are 2 MRI visits (1 at the beginning of the study and one at the end), 5 assessment visits (3 baseline assessments and 2 post assessments), and a total of 20 training sessions (in between the baselines and the post assessments). Compensation for full participation in this study is $350.

This is a great opportunity for all to gain experience participating in a clinical research study. All participation would not only contribute to advancing our understanding of perceptual learning and how the brain processes vision, but also holds the potential to improve outcomes for those with central vision loss.

If you or someone you know may be interested, please consider participating.

For more information or to express interest, please email mcmaxwell@uabmc.edu or text or call 205-410-4041, or visit go.uab.edu/brainstudy to sign up!

Thank you for your time and consideration!
Two Tuesdays, Dec. 24 and Dec. 31, will be designated as paid holidays to enable UAB and UAB Medicine employees additional time to spend with their families and friends.

J. Claude Bennett, M.D., who served as UAB president from 1993 to 1996, passed away on Aug. 11, 2024, at age 90.

Located in the UAB Police and Public Safety building parking lot, the zone has video surveillance, a UAB Help Phone and is well lit. The parking spot is designated with a sign and bright green paint on the asphalt.

Participants between the ages of 35 and 65 are needed for this study. The purpose of the study is to fill in what we don’t know about how schizophrenia affects people as they get older. We want to find out what we can do to help older individuals with schizophrenia live better lives. The study includes 4 visits over the course of two weeks. The screening visit will take 2 hours. The first study visit will take 3 hours. The second study visit will take 2 hours. The third study visit will take 9 hours. This study will include: a clinical interview, cognitive batteries, questionnaires and assessments related to your daily and psychiatric functioning, two 90 minute MRI scans of your brain, a fasting blood draw, and a urine drug screen and pregnancy test (for females). Compensation is up to $310. TO SEE IF YOU QUALIFY PLEASE CONTACT (205) 934-8203.

Page 3 of 69